4//SEC Filing
Nixon Ronald T 4
Accession 0001493152-25-008520
CIK 0000714256other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:15 PM ET
Size
7.9 KB
Accession
0001493152-25-008520
Insider Transaction Report
Form 4
Nixon Ronald T
DirectorChief Executive Officer10% Owner
Transactions
- Award
Common Stock
2025-02-25+7,534→ 64,042 total
Holdings
- 963,856(indirect: See Footnote)
Common Stock
- 2,452,731(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on February 25, 2026, 2027 and 2028, respectively.
- [F2]Represents shares of the Company's common stock owned of record by CGI Cellerate RX, LLC, which is a wholly owned subsidiary of Catalyst Rochal, LLC. Mr. Nixon is a manager of Catalyst Rochal, LLC. By virtue of these relationships, Mr. Nixon, Catalyst Rochal, LLC and CGI Cellerate RX, LLC may be deemed to share voting and dispositive control over the common stock. Mr. Nixon and Catalyst Rochal, LLC disclaim beneficial ownership of any common stock held or beneficially owned by CGI Cellerate RX, LLC, except to the extent of each of their pecuniary interests therein.
- [F3]Represents shares of the Company's common stock owned of record by FA Sanara, LLC ("FA Sanara"). FA Sanara is managed by Family Alignment, LLC ("Family"), which is managed by Catalyst Group, Inc. ("Catalyst"). Mr. Nixon is a controlling shareholder and President of Catalyst. Mr. Nixon, Catalyst, Family and FA Sanara may be deemed to share voting and dispositive control over the common stock. Mr. Nixon, Catalyst and Family disclaim beneficial ownership of any common stock held or beneficially owned by FA Sanara, except to the extent of each of their pecuniary interests therein.
Documents
Issuer
Sanara MedTech Inc.
CIK 0000714256
Entity typeother
Related Parties
1- filerCIK 0001322573
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:15 PM ET
- Size
- 7.9 KB